Management of refractory fistulizing pouchitis with infliximab

European Review for Medical and Pharmacological Sciences

Volumn 8, Issue 5, 2004, Pages 239-246

  Viscido, A ^a   Kohn, A ^b   Papi, C ^c   Caprilli, R ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^c SAN FILIPPO NERI HOSPITAL   (Italy)

Author keywords

Fistulae; Ileo pouch anal anastomosis (IPAA); Infliximab; Pouchitis; Ulcerative colitis (UC)

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; AZATHIOPRINE; CIPROFLOXACIN; INFLIXIMAB; METRONIDAZOLE; PROBIOTIC AGENT; STEROID;

ADULT; ANAMNESIS; ANUS FISTULA; ARTHRALGIA; ARTICLE; BLADDER FISTULA; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ACTIVITY; DRUG EFFICACY; DRUG INFUSION; DRUG RESPONSE; ENDOSCOPY; ERYTHEMA NODOSUM; FEMALE; FOLLOW UP; HERPES ZOSTER; HISTOPATHOLOGY; HUMAN; ILEITIS; ILEOANAL ANASTOMOSIS; MALE; OPEN STUDY; OUTCOMES RESEARCH; PATIENT CARE; PHYSICAL EXAMINATION; QUALITY OF LIFE; REMISSION; ULCERATIVE COLITIS; VAGINA DISEASE;

ADULT; ANTIBODIES, MONOCLONAL; COLITIS, ULCERATIVE; COLONIC POUCHES; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL AGENTS; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 10644236239     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Dozois RR, Kelly KA. The surgical management of ulcerative colitis. In: Kirsner JB, ed. Inflammatory Bowel Disease. 5th ed. Philadelphia: WB Saunders company, 2000: 626-657.
2. Sandborn WJ. Pouchitis in the Kock continent ileostomy and the ileoanal Pouch. In: Kirsner JB, ed. Inflammatory Bowel Disease. 5th ed. Philadelphia: WB Saunders company, 2000: 736-747.
3. Sandborn WJ. Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis and treatment. Gastroenterology 1994; 107: 1856-1860.
4. Patel RT, Bain I, Youngs D, Keighley MRB. Cytochine production in pouchitis is similar to that in ulcerative colitis. Dis Colon Rectum 1995; 38: 831.
5. Bulois P, Tremaine WJ, Maunoury V, et al. Pouchitis is associated with mucosal imbalance between interleukin-8 and interleukin-10. Inflamm Bowel Dis 2000; 6: 157-164.
6. Evegenikos N, Bartolo DCC, Hamer-Hodges DW, Gosh S. Assessment of ileoanal pouch inflammation by interleukin 1β and interleukin 8 concentrations in the gut lumen. Dis Colon Rectum 2002; 45: 249-255.
7. Patel RT, Pall AA, Adu D, Keighley MR. Circulating adhesion molecules in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995; 7: 1037-1041.
8. Sandborn WJ, Tremaine WJ, Batts KP, Pemberthon JH, Phillips S. Pouchitis after ileal pouch-anal anastomosis: a pouchitis disease activity index. Mayo Clin Proc 1994; 69: 409-415.
9. Shen B, Achkar JP, Lashner BA, et al. Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis. Gastroenterology 2001; 121: 261-267.
10. Sandborn WJ. Pouchitis: definition, risk factors, frequency, natural history, classification, and public health perspective. In: McLeod RS, Martin F, Sutherland LR, et al. eds. Trends in inflammatory bowel disease 1996. Lancaster, UK, Kluwer Academic Publishers, 1997: 51-63.
11. Mimura T, Rizzello F, Helwig U, et al. Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis. Aliment Pharmacol Ther 2002; 16: 909-917.
12. Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000; 119: 305-309.
13. Goldstein NS, Sanford WW, Bodzin JH. Crohn's-like complications in patients with ulcerative colitis after total proctocolectomy and ileal pouch-anal anastomosis. Am J Surg Pathol 1998; 22: 1040-1041.
14. Dayton MT, Larsen KR, Christiansen DD. Similar functional results and complications after ileal pouch-anal anastomosis in patients with indeterminate vs ulcerative colitis. Arch Surg 2002; 137: 690-695.
15. MacLean AR, O'Connor B, Parkes R, Cohen Z, McLeod RS. Reconstructive surgery for failed ileal pouch-anal anastomosis: a viable surgical option with acceptable results. Dis Colon Rectum 2002; 45: 880-886.
16. MacRae HM, McLeod RS, Cohen Z, O'Connor BI, Ton EN. Risk factors for pelvic failure. Dis Colon Rectum 1997; 40: 257-262.
17. Gecim IE, Wolff BG, Pemberton JH, Devine RM, Dozois RR. Does technique of anastomosis play any role in developing late perianal abscess or fistula? Dis Colon Rectum 2000; 43: 1241-1245.
18. Ricart E, Panaccione R, Loftus EV, Tremaine WJ, Sandborn WJ. Successful Management of Crohn's disease of the ileoanal pouch with Infliximab. Gastroenterology 1999; 117: 429-432.
19. Colombel JF, Ricart E, Loftus EV, et al. Management of Crohn's disease of the ileoanal pouch with Infliximab. Am J Gastroenterol 2003; 98: 2239-2244.
20. Sheperd NA, Hulten L, Tytgat GNI, et al. Workshop: Pouchitis. Int J Colorect Dis 1989; 4: 205-229.
21. Warren BF, Shepherd NA. The role of pathology in pelvic ileal reservoir surgery. Int J Colorect Dis 1992; 7: 68-75.
22. Jenkins D, Balsitis M, Gallivan S, et al. Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol 1997; 50: 93-105.
23. Viscido A, Habib FI, Kohn A, et al. Infliximab in refractory pouchitis complicated by fistulae following ileo-anal pouch for ulcerative colitis. Aliment Pharmacol Ther 2003; 17: 1263-1271.
24. Martin A, Leone L, Fries W, Naccarato R. Quality of life in inflammatory bowel disease. Ital J Gastroenterol 1995; 27: 450.454.
25. Subramani K, Harpaz N, Bilotta J, et al. Refractory pouchitis: does it reflect underlying Crohn's disease? Gut 1993; 34: 1539-1542.
26. Facklis K, Plevy SE, Vasiliauskas EA, et al. Crohn's disease-associated genetic marker is seen in medically unresponsive ulcerative colitis patients and may be associated with pouch-specific complications. Dis Colon Rectum 1999; 42: 601-605.
27. Kuhbacher T, Gionchetti P, Hampe J, et al. Activation of signal-transducer and activator of transcription 1 (STAT1) in pouchitis. Clin Exp Immunol 2001; 123: 395-401.
28. Achkar JP, Lashner BA. TNF haplotype and pouch complications: Invited editorial. Dis Colon Rectum 1999; 42: 605-606.